Indwelling Catheters Market Report 2026

The indwelling catheters market size has grown strongly in recent years. It will grow from $4.62 billion in 2025 to $5.06 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing prevalence of urinary disorders, rising number of surgical procedures, growth in hospitalized patient population, wider adoption of foley catheters, improvements in basic catheter materials.

The indwelling catheters market size is expected to see strong growth in the next few years. It will grow to $7.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to aging population growth, increasing demand for chronic care management, rising adoption of home healthcare services, technological advancements in catheter materials, growing awareness of catheter-associated infection prevention. Major trends in the forecast period include rising demand for long-term urinary care, increasing adoption of silicone-based catheters, growing focus on infection prevention and patient safety, expansion of home healthcare catheter use, product innovations for improved patient comfort.

The increasing incidence of prostate cancer is expected to drive the growth of the indwelling catheters market in the coming years. Prostate cancer is characterized by the uncontrolled growth of cells in the prostate gland, which may potentially spread beyond the gland. Factors contributing to the rising incidence of prostate cancer include an ageing population, improved diagnostic techniques, environmental exposures, dietary influences, and genetic predispositions in certain ethnic groups. Indwelling catheters are essential in managing prostate cancer, providing a reliable method for urinary drainage in patients experiencing urinary retention or obstruction due to tumor effects on the prostate. For example, in January 2023, the American Cancer Society, a US-based non-profit organization, reported that new cases of prostate cancer in the US rose from 268,490 in 2022 to 288,300 in 2023. Deaths due to prostate cancer also slightly increased, from 34,500 in 2022 to 34,700 in 2023. Consequently, the growing incidence of prostate cancer supports the expansion of the indwelling catheters market.

The rising prevalence of urinary disorders is expected to propel the growth of the indwelling catheters market in the coming years. Urinary disorders include conditions affecting the kidneys, bladder, ureters, or urethra, resulting in difficulties such as trouble urinating, incontinence, infections, or kidney stones. Contributing factors to the increasing prevalence of urinary disorders include an aging population, lifestyle changes, obesity, diabetes, and greater awareness of urinary health. Indwelling catheters facilitate continuous bladder drainage, effectively managing urinary disorders by relieving obstruction, reducing retention, and preventing complications related to incomplete voiding. For instance, in October 2023, the UK’s National Health Service (NHS) reported that in 2022/23 there were 147,285 hospital admissions with a primary diagnosis of urinary tract infection (UTI), 56% of which (82,392 cases) involved individuals over the age of 65. The 80-84 age group had the highest number of admissions, totaling 17,280. As a result, the growing prevalence of urinary disorders drives demand for indwelling catheters.

In December 2023, Bactiguard Holding AB, a Sweden-based specialist in coated medical devices, partnered with Becton Dickinson and Company (BD), granting BD exclusive global rights, excluding China, to commercialize Bactiguard-coated Foley catheters. This collaboration aims to expand global access to advanced infection-preventive indwelling urinary catheters, strengthen BD’s portfolio in urinary management solutions, and support Bactiguard’s shift toward a licensing-focused growth strategy. Becton Dickinson and Company is a US-based global medical technology company with a wide-ranging portfolio that includes indwelling urinary catheter products.

Major companies operating in the indwelling catheters market are Cardinal Health Inc., Medline Industries Inc., Becton, Dickinson, and Company, Coloplast Corp., Teleflex Incorporated, Cook Medical LLC, B. Braun Medical Inc., ConvaTec Inc., Amsino International Inc., Sterimed Medical Devices Pvt. Ltd., Angiplast Pvt. Ltd., Mais India Medical Devices, Bactiguard AB, GPC Medical Ltd., Rocket Medical plc, Nikotech Pvt. Ltd., Ribbel International Ltd., Poiesis Medical LLC, Manish Medi Innovation.

North America was the largest region in the indwelling catheters market in 2025. The regions covered in the indwelling catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the indwelling catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the indwelling catheters market by increasing the cost of raw materials such as silicone, latex, and pvc, as well as manufacturing equipment. These impacts are most evident in transurethral and suprapubic catheter segments, particularly in asia-pacific and europe where cross-border material sourcing is significant. Higher tariffs have increased procurement costs for hospitals and clinics. However, tariffs are also driving local manufacturing initiatives, supply chain diversification, and cost-optimized production strategies, supporting long-term market resilience.

The indwelling catheters market research report is one of a series of new reports that provides indwelling catheters market statistics, including indwelling catheters industry global market size, regional shares, competitors with a indwelling catheters market share, detailed indwelling catheters market segments, market trends and opportunities, and any further data you may need to thrive in the indwelling catheters industry. This indwelling catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Indwelling catheters are medical devices inserted into the bladder and left in place to allow continuous urine drainage. They are used to manage urinary retention, incontinence, or other conditions that require prolonged bladder emptying, particularly in patients with limited mobility or during surgical and post-operative care.

The primary types of indwelling catheters are transurethral catheters and suprapubic catheters. Transurethral catheters are inserted through the urethra into the bladder to drain urine and are commonly used for urinary retention or incontinence management. Indwelling catheters are made from various materials, including latex, silicone, and polyvinyl chloride (PVC). These catheters are intended for applications such as urinary retention, urinary incontinence, and post-surgery care, and are utilized by different end users, including hospitals, clinics, and ambulatory surgical centers (ASCs).

The indwelling catheters market consists of sales of central venous catheters, peripherally inserted central catheters, and neurovascular catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.